Metagenics Bone Builder Prime®, 270 Tablets
UPC: 755571013187
Metagenics Bone Builder Prime is a bone health supplement formulated for postmenopausal women, according to the manufacturer. It provides calcium from microcrystalline hydroxyapatite (MCHC), a source that includes naturally occurring minerals like phosphorus, along with vitamin D and ipriflavone, which are intended to support bone density and growth factors.
This product is backed by over 30 years of scientific research, as stated by Metagenics, with MCHC chosen for its role in bone structure. The dosage of 150 mg ipriflavone per serving aligns with amounts used in some clinical studies on bone health. It comes in a 270-tablet bottle, providing a three-month supply when taken as directed at three tablets daily, and is available only in this size. Certifications include Non-GMO and Gluten-Free.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Total Carbohydrate | <1 g | <1%** |
| Dietary Fiber | <1 g | 2%** |
| Vitamin D | 15 mcg (600 IU) | 75% |
| Calcium | 660 mg | 51% |
| Phosphorus | 380 mg | 30% |
| Microcrystalline Hydroxyapatite | 1.5 g | *** |
| Ipriflavone | 150 mg | *** |
| † Daily Value not established | ||
Other Ingredients
Microcrystalline cellulose, stearic acid (vegetable), croscarmellose sodium, silica, and coating (hypromellose, medium chain triglycerides, and hydroxypropylcellulose).
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Take three tablets once daily or as directed by your healthcare practitioner.
Warning
If pregnant, nursing, or taking medication, consult your healthcare practitioner before use. Keep out of reach of children. Tamper evident: Do not use if safety seal is missing or broken. Storage: Keep tightly closed in a cool, dry place.
Product Info
- Brand
- Metagenics
- UPC
- 755571013187
- Package Qty
- 270 count
- Dimensions
- 5.45 x 2.9 x 2.85 in
- Shipping Weight
- 1.29 lb
- First Available
- 06/2023
